These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 17591570

  • 1. Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity.
    Hodgson DC, Hudson MM, Constine LS.
    Semin Radiat Oncol; 2007 Jul; 17(3):230-42. PubMed ID: 17591570
    [Abstract] [Full Text] [Related]

  • 2. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
    Sénécal D, Jais JP, Desablens B, Berthou C, Casassus P, Moles MP, Delwail V, Gastinne T, Colonna P, Andrieu JM.
    Cancer; 2008 Feb 15; 112(4):846-55. PubMed ID: 18072259
    [Abstract] [Full Text] [Related]

  • 3. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.
    Campbell BA, Voss N, Pickles T, Morris J, Gascoyne RD, Savage KJ, Connors JM.
    J Clin Oncol; 2008 Nov 10; 26(32):5170-4. PubMed ID: 18838714
    [Abstract] [Full Text] [Related]

  • 4. The impact of involved field radiation therapy for patients receiving high-dose chemotherapy followed by hematopoietic progenitor cell transplant for the treatment of relapsed or refractory Hodgkin disease.
    Wendland MM, Asch JD, Pulsipher MA, Thomson JW, Shrieve DC, Gaffney DK.
    Am J Clin Oncol; 2006 Apr 10; 29(2):189-95. PubMed ID: 16601441
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. First-line treatment of Hodgkin's lymphoma.
    Klimm B, Engert A, Diehl V.
    Curr Hematol Rep; 2005 Jan 10; 4(1):15-22. PubMed ID: 15610655
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
    Engert A, Franklin J, Eich HT, Brillant C, Sehlen S, Cartoni C, Herrmann R, Pfreundschuh M, Sieber M, Tesch H, Franke A, Koch P, de Wit M, Paulus U, Hasenclever D, Loeffler M, Müller RP, Müller-Hermelink HK, Dühmke E, Diehl V.
    J Clin Oncol; 2007 Aug 10; 25(23):3495-502. PubMed ID: 17606976
    [Abstract] [Full Text] [Related]

  • 14. [Preliminary results of thyroid function assessment in children and adolescents with Hodgkin's disease (HD) treated according to PGP-HD-97 protocol].
    Moryl-Bujakowska A, Balwierz W, Sztefko K.
    Przegl Lek; 2004 Aug 10; 61 Suppl 2():81-4. PubMed ID: 15686053
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hodgkin's lymphoma in the young child.
    Belgaumi AF.
    Transfus Apher Sci; 2010 Apr 10; 42(2):163-7. PubMed ID: 20100668
    [Abstract] [Full Text] [Related]

  • 19. Radiotherapy in early stage classical Hodgkin lymphoma: past, present and future.
    Zhang W.
    Chin Clin Oncol; 2015 Mar 10; 4(1):6. PubMed ID: 25841713
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.